ABILIFY MYCITE KIT®

Drug Information Related Patent
Hold Company
OTSUKA
Learn More
Dosage and Administration
TABLET;ORAL
Specification
2MG; 5MG; 10MG; 15MG; 20MG; 30MG
Indication
ABILIFY MYCITE KIT® is used in the treatment of schizophrenia in adults, bipolar I disorder, and major depressive disorder in adults.
Use
Instructions for Use
API
ARIPIPRAZOLE
API Structure
We Supply
ARIPIPRAZOLE
Note:

In-house Standard/EP/USP
Facility GMP
USMF/CDE/CEP

null
Note:

null

null
Note:

null

Drug Patent
Patent NoExpiration Date
104411942029/7/26
105175072032/6/13
112293782031/7/11
114644232030/9/15
114769522026/4/28
79780642026/9/14
80176152024/6/16
81140212030/6/21
82589622030/11/25
85454022030/4/27
85472482030/12/18
86748252029/4/9
87181932029/12/5
87593502027/3/2
88477662030/3/29
89450052029/8/19
89562882029/7/6
89614122030/11/17
90607082029/3/5
91195542028/12/16
91259392026/7/28
91495772029/12/15
92580352029/3/5
92689092033/10/15
93204552031/12/15
93871822023/12/25
94333712029/9/15
94445032027/11/19
99419312030/11/4
API Patent
Patent NoExpiration Date
80176152024/6/16
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION
CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen-ING. All Rights Reserved.
dcat
Member of
dcat
Top